首页> 外文期刊>Cureus. >Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels
【24h】

Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels

机译:自我报告的Morisky八件药物药物粘附量表,毒素计数方法与丸计数方法相关,与血清脂质谱参数和血清HMGCOA还原酶水平相关

获取原文
       

摘要

Background It is imperative that non-compliance with statins be identified and addressed to maximize their clinical benefits. Patient self-reporting methods are convenient to apply in clinical practice but need to be validated. Objective We studied the concordance of a patient self-report method, Morisky eight-item medication adherence scale (MMAS)), with the pill count method in measuring adherence with statins and their correlation with extended lipid profile parameters and serum hydroxyl-methylglutaryl coenzyme A reductase (HMGCoA-R) enzyme levels. Methods MMAS and the pill count method were used to measure the adherence with statins in patients on statins for any duration. Patients were subjected to an estimation of extended lipid profile and serum HMGCoA-R levels at the end of three months follow-up. Results Out of a total of 200 patients included in the study, 117 patients had a low adherence (score less than 6 on MMAS) whereas 65 and 18 patients had medium (score 6 or 7) and high adherence (score of 8), respectively. The majority of patients who had low adherence to statins by MMAS were nonadherent by the pill count method yielding a concordance of 96.5%. Medium or high adherence to statins by the MMAS method had a concordance of 89.1% with the pill count method. The levels of total cholesterol, low-density lipoprotein-cholesterol, apolipoprotein B, and HMGCoA-R were?negatively correlated with compliance measured by pill count and MMAS in a statistically significant way and with similar correlation coefficients. HMGCoA-R levels demonstrated a plateau phenomenon, with levels being 9-10 ng/ml when compliance with statin therapy was greater than 60% by pill count and greater than 6 on the Morisky scale. Conclusion In conclusion, MMAS and the pill count method?showed concordance in measuring adherence to statins. These methods need to be explored further for their interchangeability as surrogates for biomarker levels.
机译:背景技术必须确定不遵守他汀类药物并解决,以最大限度地提高其临床效益。患者自我报告方法可方便地应用于临床实践,但需要验证。目的我们研究了患者自我报告方法,MORSKY八项药物粘附量表(MMAS))的一致性,药丸数量方法测量与他汀类药物的粘附性及其与延长脂质分布参数的相关性和血清羟基 - 甲基谷辅酶A.还原酶(HMGCOA-R)酶水平。方法MMA和丸计数方法用于测量他汀类药物中的依赖于他汀类药物的任何持续时间。患者在三个月的后续后期估计延长的脂质曲线和血清HMGCOA-R水平。结果在研究中共有200名患者,117名患者的粘附性低(比分小于6,MMA少6名),而65和18名患者分别具有中等(得分6或7)和高粘附(得分为8) 。通过MMA粘附低粘附的大多数患者是不正常的,避孕药数量是96.5%的一致性。通过MMS方法对他汀类药物的中等或高粘附性具有89.1%的一致性,药丸数量方法。总胆固醇,低密度脂蛋白 - 胆固醇,载脂蛋白B和HMGCOA-R的水平是疑处与蛋白质计数和MMA以统计显着的方式和类似的相关系数测量的顺应性。 HMGCOA-R水平展示了平台现象,水平为9-10ng / ml,当遵守蛋白蛋白疗法大于60%的药丸数量,而且在动力系统上大于6。结论总结,MMAS和丸计数方法?在衡量他汀类药物的粘附方面表现出一致。这些方法需要进一步探索它们作为生物标志物水平的替代品的互换性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号